414 related articles for article (PubMed ID: 31017018)
1. Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys.
Hordeaux J; Hinderer C; Buza EL; Louboutin JP; Jahan T; Bell P; Chichester JA; Tarantal AF; Wilson JM
Hum Gene Ther; 2019 Aug; 30(8):957-966. PubMed ID: 31017018
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates.
Hinderer C; Bell P; Louboutin JP; Zhu Y; Yu H; Lin G; Choa R; Gurda BL; Bagel J; O'Donnell P; Sikora T; Ruane T; Wang P; Tarantal AF; Casal ML; Haskins ME; Wilson JM
Mol Ther; 2015 Aug; 23(8):1298-1307. PubMed ID: 26022732
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice.
Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E
Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.
Belur LR; Temme A; Podetz-Pedersen KM; Riedl M; Vulchanova L; Robinson N; Hanson LR; Kozarsky KF; Orchard PJ; Frey WH; Low WC; McIvor RS
Hum Gene Ther; 2017 Jul; 28(7):576-587. PubMed ID: 28462595
[TBL] [Abstract][Full Text] [Related]
5. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.
Hartung SD; Frandsen JL; Pan D; Koniar BL; Graupman P; Gunther R; Low WC; Whitley CB; McIvor RS
Mol Ther; 2004 Jun; 9(6):866-75. PubMed ID: 15194053
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.
Towne C; Pertin M; Beggah AT; Aebischer P; Decosterd I
Mol Pain; 2009 Sep; 5():52. PubMed ID: 19737386
[TBL] [Abstract][Full Text] [Related]
7. Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I.
Miyadera K; Conatser L; Llanga TA; Carlin K; O'Donnell P; Bagel J; Song L; Kurtzberg J; Samulski RJ; Gilger B; Hirsch ML
Mol Ther; 2020 Jun; 28(6):1455-1463. PubMed ID: 32330426
[TBL] [Abstract][Full Text] [Related]
8. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
9. Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques.
Hordeaux J; Hinderer C; Goode T; Katz N; Buza EL; Bell P; Calcedo R; Richman LK; Wilson JM
Mol Ther Methods Clin Dev; 2018 Sep; 10():79-88. PubMed ID: 30073179
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene.
Hartung SD; Reddy RG; Whitley CB; McIvor RS
Hum Gene Ther; 1999 Sep; 10(13):2163-72. PubMed ID: 10498248
[TBL] [Abstract][Full Text] [Related]
11. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM
Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426
[TBL] [Abstract][Full Text] [Related]
12. Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model.
Hinderer C; Bell P; Louboutin JP; Katz N; Zhu Y; Lin G; Choa R; Bagel J; O'Donnell P; Fitzgerald CA; Langan T; Wang P; Casal ML; Haskins ME; Wilson JM
Mol Genet Metab; 2016 Sep; 119(1-2):124-30. PubMed ID: 27386755
[TBL] [Abstract][Full Text] [Related]
13. AAV Gene Therapy for MPS1-associated Corneal Blindness.
Vance M; Llanga T; Bennett W; Woodard K; Murlidharan G; Chungfat N; Asokan A; Gilger B; Kurtzberg J; Samulski RJ; Hirsch ML
Sci Rep; 2016 Feb; 6():22131. PubMed ID: 26899286
[TBL] [Abstract][Full Text] [Related]
14. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
15. Human alpha-iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution.
Ciron C; Cressant A; Roux F; Raoul S; Cherel Y; Hantraye P; Déglon N; Schwartz B; Barkats M; Heard JM; Tardieu M; Moullier P; Colle MA
Hum Gene Ther; 2009 Apr; 20(4):350-60. PubMed ID: 19272011
[TBL] [Abstract][Full Text] [Related]
16. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta).
Wang L; Bell P; Lin J; Calcedo R; Tarantal AF; Wilson JM
Mol Ther; 2011 Nov; 19(11):2012-20. PubMed ID: 21811248
[TBL] [Abstract][Full Text] [Related]
17. Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology.
Hordeaux J; Buza EL; Dyer C; Goode T; Mitchell TW; Richman L; Denton N; Hinderer C; Katz N; Schmid R; Miller R; Choudhury GR; Horiuchi M; Nambiar K; Yan H; Li M; Wilson JM
Hum Gene Ther; 2020 Aug; 31(15-16):808-818. PubMed ID: 32845779
[TBL] [Abstract][Full Text] [Related]
18. Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice.
Hinderer C; Katz N; Louboutin JP; Bell P; Yu H; Nayal M; Kozarsky K; O'Brien WT; Goode T; Wilson JM
Hum Gene Ther; 2016 Nov; 27(11):906-915. PubMed ID: 27510804
[TBL] [Abstract][Full Text] [Related]
19. A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I.
Ou L; Przybilla MJ; Ahlat O; Kim S; Overn P; Jarnes J; O'Sullivan MG; Whitley CB
Mol Ther; 2020 Jun; 28(6):1442-1454. PubMed ID: 32278382
[TBL] [Abstract][Full Text] [Related]
20. Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy.
Di Domenico C; Di Napoli D; Gonzalez Y Reyero E; Lombardo A; Naldini L; Di Natale P
Hum Gene Ther; 2006 Nov; 17(11):1112-21. PubMed ID: 17044753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
